ABIVAX (ABVX) total liabilities

Total liabilities · fiscal 2025
€129.14M

ABIVAX (ABVX) had total liabilities of €129.14M at the end of fiscal 2025 (December 31, 2025). That is 21.6% lower than the €164.64M of fiscal 2024. Figures as of 19 Nov 2026, 11:31 UTC, from Yahoo Finance.

Key facts

Total liabilities, fiscal 2025
€129.14M
Change on fiscal 2024
−21.6%
Highest on record
€164.64Mfiscal 2024
Lowest on record
€68.36Mfiscal 2022
Fiscal years on record
42022–2025

Figures as of . Statements from Yahoo Finance. Amounts are in EUR. Figures, not advice.

ABIVAX total liabilities, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was €164.64M in fiscal 2024 and the lowest €68.36M in fiscal 2022.

History · 4 fiscal years

Total liabilities by fiscal year

ABIVAX total liabilities, year by year

ABIVAX (ABVX) total liabilities by fiscal year
Fiscal yearTotal liabilitiesChangeYear ended
2025€129.14M 21.6% down
2024€164.64M 25.6% up
2023€131.05M 91.7% up
2022€68.36M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest.

How to read it

It is broader than debt: read it against total assets, and remember that for a bank or an insurer customer deposits and policy reserves are liabilities too.

Total liabilities at health care companies of similar size

Total liabilities of ABIVAX and comparable companies
CompanyTotal liabilitiesFiscal year
Alkermes ALKS$667.70M2025
PACS Group PACS$4.63B2025
Kiniksa Pharmaceuticals International KNSA$196.03M2025
ImmunityBio IBRX$1.00B2025
Cytokinetics CYTK$2.08B2025
ABIVAX ABVX€129.14M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on ABVX

ABIVAX, figure by figure

ABIVAX (ABVX) overview: price, valuation and scorecardAll health care companies by market value

ABIVAX total liabilities: questions and answers

How large are ABIVAX's total liabilities?

ABIVAX (ABVX) had total liabilities of €129.14M at the end of fiscal 2025 (December 31, 2025). That is 21.6% lower than the €164.64M of fiscal 2024.

What are the highest and lowest total liabilities figures on record for ABIVAX?

Across the 4 fiscal years on record (2022–2025), the highest was €164.64M in fiscal 2024 and the lowest €68.36M in fiscal 2022.

How is ABIVAX's total liabilities calculated?

Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest. For ABIVAX it is on record here for 4 fiscal years, 2022 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “ABIVAX (ABVX) total liabilities”, data as of 19 November 2026. https://funkfolio.com/stock/ABVX/total-liabilities

Underlying data: Yahoo Finance.